Market
Research Future has published its Half-Cooked Research Report on the Global G
Protein-Coupled Receptors Market.
Market Highlights
According
to MRFR analysis, the global G Protein Coupled Receptors Market Size is expected to register a CAGR of 7.1% during the
forecast period of 2019 to 2025 and was valued at USD 3,100 million in 2018.
GPCRs are
the largest and the most diverse group of membrane receptors in eukaryotes.
They are also called transmembrane domain receptors, 7TM receptors, serpentine
receptor, and G protein-linked receptors. They detect molecules outside the
cell and activate internal signal transduction pathways.
The
growth of global G Protein Coupled Receptors Market Size is driven by various
factors such as growing use of G protein combined receptors in medicating
disclosure and advancement forms, increasing the number of drugs under clinical
and preclinical studies that target these receptors. However, the high cost
involved in the maintenance of GPCR cell lines is expected to curb the growth
of the global G protein coupled receptor market.
Several
market players currently dominate the global G Protein Coupled Receptors Market
Size. The key players are involved in product launches and strategic
collaborations to strengthen their market positions.
Regional Analysis
The
market has been divided, by region, into the Americas, Europe, Asia-Pacific,
and the Middle East & Africa. The Americas is expected to be the largest
market owing to the presence of a large number of approved drugs that target
G-protein coupled receptors. The G Protein Coupled Receptors Market Size in the
Americas has further been branched into North America and Latin America, with
the North American market divided into the US and Canada. The European G
Protein Coupled Receptors Market Size has been categorized as Western Europe
and Eastern Europe. The Western European market has further been classified as
Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The G
Protein Coupled Receptors Market Size in Asia-Pacific has been segmented into
Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The
rising number of approved drugs that target GPCRs has boosted the growth of the
G Protein Coupled Receptors Market Size, the market in Asia-Pacific is expected
to be the fastest-growing. The G protein coupled receptor market in the Middle
East & Africa has been divided into the Middle East and Africa.
Browse Full Report Details
@ https://www.marketresearchfuture.com/reports/g-protein-coupled-receptors-market-8356
Segmentation
The
global G Protein Coupled Receptors Market Size has been segmented based on the
product, assay type, and application.
The
market, based on product, has been divided into cell lines, detection kits,
cell culture reagents, ligands, and others. The detection kits segment is
likely to be the fastest during the review period as they are ready to use kits
that includes all cells and reagents to perform functional GPCRs assay in live
cells thus driving the growth of the global G protein coupled receptor market.
The global G protein coupled receptor market has been bifurcated,
on the basis of assay type, into functional calcium assays, cAMP functional
assays, cGMP assays, GTP gamma S binding assays, ß-Arrestin Functional Assays,
internalization assays, and others. Calcium functional assays are the fastest
segment as it has numerous advantages such as user configurability, ease in the
estimation of calcium flux thus driving the growth of this segment in the GPCR
market.
The global G Protein Coupled Receptors Market Size has been
segmented, based on application into the cardiovascular system, oncology,
immunology, respiratory system, central nervous system, and others. The
cardiovascular system is the largest segment as angiotensin II, and
β-adrenergic receptors provide therapy for a wide range of cardiovascular
disease such as heart failure. Approximately 17.9 million people die each year
from cardiovascular disease thus rising the growth of G protein coupled
receptor market.
Key Players
Some of the key players in the global G protein coupled receptor market are Thermo
Fisher Scientific, Inc., Cisbio, Promega Corporation, Abcam PLC, PerkinElmer
Inc., Merck Group, HD Biosciences Co., Ltd, QIAGEN, Enzo Life Sciences, and
Inc.BD
No comments:
Post a Comment